BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1618998)

  • 1. Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia.
    Daughaday WH; Trivedi B
    J Clin Endocrinol Metab; 1992 Jul; 75(1):110-5. PubMed ID: 1618998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of serum peptides with immunoactivity detected by a radioimmunoassay for proinsulin-like growth factor-II E domain: description of a free E domain peptide in serum.
    Daughaday WH; Trivedi B
    J Clin Endocrinol Metab; 1992 Aug; 75(2):641-5. PubMed ID: 1379260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of proinsulin-like growth factor-II E-region immunoreactivity in serum and other biological fluids.
    Liu F; Baker BK; Powell DR; Hintz RL
    J Clin Endocrinol Metab; 1993 May; 76(5):1095-100. PubMed ID: 8496298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive proinsulin-like growth factor-II levels in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin.
    Tally M; Eriksson U; Thorén M; Brismar K; Hall K
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1576-81. PubMed ID: 7989458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.
    Daughaday WH; Trivedi B; Baxter RC
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5823-7. PubMed ID: 7685912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia.
    van Doorn J; Hoogerbrugge CM; Koster JG; Bloemen RJ; Hoekman K; Mudde AH; van Buul-Offers SC
    Clin Chem; 2002 Oct; 48(10):1739-50. PubMed ID: 12324491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia.
    Hizuka N; Fukuda I; Takano K; Okubo Y; Asakawa-Yasumoto K; Demura H
    Endocr J; 1998 Apr; 45 Suppl():S61-5. PubMed ID: 9790231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-domain peptide of rat proinsulin-like growth factor-II: validation of a radioimmunoassay and measurement in culture medium and rat serum.
    Hylka VW; Kent SB; Straus DS
    Endocrinology; 1987 May; 120(5):2050-8. PubMed ID: 3569124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated.
    Hizuka N; Fukuda I; Takano K; Asakawa-Yasumoto K; Okubo Y; Demura H
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2875-7. PubMed ID: 9709962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
    Frystyk J; Skjaerbaek C; Zapf J; Orskov H
    Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia.
    Fukuda I; Hizuka N; Ishikawa Y; Yasumoto K; Murakami Y; Sata A; Morita J; Kurimoto M; Okubo Y; Takano K
    Growth Horm IGF Res; 2006 Aug; 16(4):211-6. PubMed ID: 16860583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysis.
    Enjoh T; Hizuka N; Perdue JF; Takano K; Fujiwara H; Higashihashi N; Marumoto Y; Fukuda I; Sakano K
    J Clin Endocrinol Metab; 1993 Aug; 77(2):510-7. PubMed ID: 7688378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of glucose-regulatory hormones in patients with non-islet cell tumor hypoglycemia: including a review of the literature.
    Fukuda I; Asai A; Nagamine T; Harada T; Tanimura-Inagaki K; Hizuka N; Sugihara H
    Endocr J; 2017 Jul; 64(7):719-726. PubMed ID: 28529277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia.
    Katz LE; Liu F; Baker B; Agus MS; Nunn SE; Hintz RL; Cohen P
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1141-6. PubMed ID: 8772589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
    Miraki-Moud F; Grossman AB; Besser M; Monson JP; Camacho-Hübner C
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3819-23. PubMed ID: 15840753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal processing of pro-IGF-II in patients with hepatoma and in some hepatitis B virus antibody-positive asymptomatic individuals.
    Daughaday WH; Wu JC; Lee SD; Kapadia M
    J Lab Clin Med; 1990 Oct; 116(4):555-62. PubMed ID: 2170553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis.
    Khosla S; Ballard FJ; Conover CA
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3867-70. PubMed ID: 12161524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic coma secondary to big insulin-like growth factor II secretion by a giant phyllodes tumor of the breast.
    Aguiar Bujanda D; Rivero Vera JC; Cabrera Suárez MA; Aguiar Morales J; Christol R; Bohn Sarmiento U; Domínguez Cabrera C; Le Bouc Y
    Breast J; 2007; 13(2):189-91. PubMed ID: 17319862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung.
    Nauck MA; Reinecke M; Perren A; Frystyk J; Berishvili G; Zwimpfer C; Figge AM; Flyvbjerg A; Lankisch PG; Blum WF; Klöppel G; Schmiegel W; Zapf J
    J Clin Endocrinol Metab; 2007 May; 92(5):1600-5. PubMed ID: 17299065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-II: possible local growth factor in pheochromocytoma.
    Gelato MC; Vassalotti J
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1168-74. PubMed ID: 2172273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.